Clinical Trial Update: Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating sequencing of anthracyclines and taxanes for locally advanced HER2-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Latin American Cooperative Oncology Group | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING